X0206 3 2022-03-24 0 0001880438 AN2 Therapeutics, Inc. ANTX 0001571820 Chanda Sanjay C/O AN2 THERAPEUTICS, INC. 1800 EL CAMINO REAL, SUITE D MENLO PARK CA 94027 0 1 0 0 Chief Development Officer Stock Option (right to buy) 0.42 2030-01-22 Common Stock 80472 D Stock Option (right to buy) 0.42 2030-09-23 Common Stock 19444 D Stock Option (right to buy) 6.60 2031-04-29 Common Stock 41665 D The option is subject to an early exercise provision and is immediately exercisable. The shares subject to the option vest as follows: 25% of the shares vested on May 21, 2020; and 1/48th of the shares vests monthly thereafter over the following three years, subject to the Reporting Person's continuous service as of such date. The option is subject to an early exercise provision and is immediately exercisable. The shares subject to the option vest as follows: 1/48th of the shares vests monthly over four years from October 5, 2020, subject to the Reporting Person's continuous service as of such date. The shares subject to the option vest as follows: 1/48th of the shares vests monthly over four years from April 30, 2021, subject to the Reporting Person's continuous service as of such date. Exhibit 24 - Power of Attorney /s/ Lucy Day, Attorney-in-Fact for Sanjay Chanda 2022-03-24